Research Paper Volume 14, Issue 7 pp 3203—3215
Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen
Figure 2. The value of APBSCT and maintenance treatment following chemo-therapy on prognosis. (A) Kaplan–Meier survival curve stratified by receiving APBSCT or not of patients without following maintenance treatment. P<0.001 (B) The impacts of maintenance treatment without APBSCT on overall survival and progression free survival. (C) The effects of maintenance treatment following APBSCT on overall survival and progression free survival.